Word

REXULTI VORTIOXETINE

Status

Dead

Status Code

404

Status Date

Tuesday, July 14, 2015

Serial Number

79134109

Registration Number

4582247

Registration Date

Tuesday, August 12, 2014

Mark Type

3000

Filing Date

Wednesday, November 28, 2012

Published for Opposition

Tuesday, May 27, 2014

Cancellation Date

Tuesday, July 14, 2015

Trademark Owner History

H. Lundbeck A-S - Original Registrant

Classifications

5 Pharmaceutical preparations for the prevention and treatment of disorders and diseases in or affecting the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of depression, psychosis, anxiety, insomnia, schizophrenia, bipolar disorder and disease, pain, alcoholism and addiction; preparations, substances, reagents and agents for diagnostic and medical purposes; all the forgoing containing in whole or substantial part vortioxetine

9 Scientific apparatus and instruments, namely, magnetic, electronic and optical data carriers containing information and data in the fields of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, and treatment and prevention of diseases and disorders; pre-recorded audio cassettes, pre-recorded video cassettes, and electronic and digital media featuring information and data in the fields of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, and treatment and prevention of diseases and disorders; downloadable electronic publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatments of diseases and disorders and prevention of diseases and disorders; recorded computer software, namely, software for searching, storing, cataloging, and indexing medical and pharmaceutical information, indexing education and sales activities and for enabling web-based access to websites, enabling database integration, and enabling web searching of websites, intranet and Internet; data processing equipment and computers; software, namely, downloadable application software containing information on the use of pharmaceutical products and on diseases and disorders of the central nervous system and the treatment thereof; downloadable electronic game software which provide information related to diseases and disorders of the central nervous system and the treatment thereof, and downloadable mobile application software that allows transmitting, sharing, receiving, downloading, displaying and transferring content, text, visual works, audio works, audiovisual works, literary works, data, files, documents and electronic works via portable and handheld electronic devices and computers in the fields of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, and treatment and prevention of diseases and disorders; application software for mobile devices, apparatus and medical instruments for controlling and managing patient medical information and interaction

10 Surgical, medical, dental and veterinary apparatus and instruments, namely, examination systems consisting primarily of medical instruments for use in diagnosing central nervous system disorders; suture materials; apparatus and instruments for diagnostic purposes for diseases and disorders of the central nervous system; integrated medical systems consisting primarily of medical instruments for central nervous system and central nervous system related diagnostics, computer hardware and software for medical information and medical information management for use of a web-based physical and psychological examination and assessment of patients and information, guidance and control of medicines

41 Education, namely, providing seminars, conferences, symposiums, workshops, courses, classes and lectures in the fields of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatments and prevention; providing of training in the fields of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatments and prevention; entertainment, namely, organizing, arranging, and conducting running, walking, golf, tennis, softball, and cycling events and cultural activities; arranging and conducting seminars, conferences, symposiums, workshops, and training courses in the fields of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatments and prevention; educational and training services in the fields of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatments of diseases and disorders and prevention of diseases and disorders; educational and training services in the field of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatments of diseases and disorders and prevention of diseases and disorders all provided electronically, on-line, via cable and Internet and other electronic media; providing nondownloadable on-line publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatments of diseases and disorders and prevention of diseases and disorders

42 Scientific and technological services in the nature of scientific research, analysis, and testing and research and design relating thereto in the field of medicine; industrial research and analysis of diseases and disorders, treatments of diseases and disorders and prevention of diseases and disorders; design and development of computer hardware and software; providing software and access to data and information in the field of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatments and prevention; pharmaceutical research and development; scientific and technological services in the nature of scientific research, analysis, and testing in the field of disorders, diseases and prevention; scientific and technological services in the nature of scientific research, analysis, and testing in the field of the central nervous system and central nervous system related disorders, diseases and pharmaceuticals; medical research and tests; clinical research and tests; diagnostic research and tests; providing for medical and medicinal information related to medical diagnostics, medicine, pharmaceuticals, diseases, disorders, treatments of diseases and disorders, and prevention of diseases and disorders in the field of research and development, science, clinical tests

44 Medical services; services in the field of psychiatry and psychology; services and advice related to medical and pharmaceutical preparations and substances; medical clinical services; medical treatment services; therapeutic medical treatment services; healthcare and medical services related to central nervous system disorders, diseases and pharmaceuticals; providing for medical and medicinal information in the field of diagnostic medicine, medical dose, pharmaceuticals, disorders, diseases, treatments and prevention; all the aforementioned services provided off-line as well as on-line through a website featuring advice and information on the foregoing

Color is not claimed as a feature of the mark.
"VORTIOXETINE"
The mark consists of the wording "REXULTI" with a sound wave emanating from the letter "I" and the wording "VORTIOXETINE" appearing directly underneath.

Trademark Events

Jul 31, 2015

Notification Of Effect Of Cancellation Of Intl Reg E-Mailed

Jul 31, 2015

Death Of International Registration

Feb 13, 2015

Final Decision Transaction Processed By Ib

Jan 27, 2015

Final Disposition Notice Sent To Ib

Jan 27, 2015

Final Disposition Processed

Nov 12, 2014

Final Disposition Notice Created, To Be Sent To Ib

Aug 12, 2014

Registered-Principal Register

Jun 12, 2014

Attorney Revoked And/Or Appointed

Jun 12, 2014

Teas Revoke/Appoint Attorney Received

May 27, 2014

Official Gazette Publication Confirmation E-Mailed

May 27, 2014

Published For Opposition

May 23, 2014

Notification Processed By Ib

May 7, 2014

Notification Of Possible Opposition Sent To Ib

May 7, 2014

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

May 7, 2014

Notification Of Notice Of Publication E-Mailed

Apr 17, 2014

Data Modification Completed

Apr 17, 2014

Withdrawn From Pub - Esu Supervisor Request

Apr 16, 2014

Law Office Publication Review Completed

Apr 16, 2014

Approved For Pub - Principal Register

Apr 16, 2014

Examiner's Amendment Entered

Apr 16, 2014

Notification Of Examiners Amendment E-Mailed

Apr 16, 2014

Examiners Amendment E-Mailed

Apr 16, 2014

Examiners Amendment -Written

Apr 8, 2014

Previous Allowance Count Withdrawn

Apr 5, 2014

Withdrawn From Pub - Og Review Query

Mar 27, 2014

Law Office Publication Review Completed

Mar 24, 2014

Approved For Pub - Principal Register

Mar 24, 2014

Examiner's Amendment Entered

Mar 24, 2014

Notification Of Examiners Amendment E-Mailed

Mar 24, 2014

Examiners Amendment E-Mailed

Mar 24, 2014

Examiners Amendment -Written

Mar 4, 2014

Teas/Email Correspondence Entered

Mar 4, 2014

Correspondence Received In Law Office

Feb 25, 2014

Assigned To Lie

Feb 19, 2014

Teas Response To Office Action Received

Sep 23, 2013

Refusal Processed By Ib

Sep 4, 2013

Non-Final Action Mailed - Refusal Sent To Ib

Sep 4, 2013

Refusal Processed By Mpu

Aug 31, 2013

Non-Final Action (Ib Refusal) Prepared For Review

Aug 30, 2013

Non-Final Action Written

Aug 24, 2013

Application Filing Receipt Mailed

Aug 20, 2013

Assigned To Examiner

Aug 20, 2013

New Application Office Supplied Data Entered In Tram

Aug 16, 2013

Limitation From Original Application Entered

Aug 15, 2013

Sn Assigned For Sect 66a Appl From Ib